NasdaqGS:BCRXBiotechs
A Look At BioCryst Pharmaceuticals (BCRX) Valuation After Recent Share Price Weakness
Recent performance snapshot
BioCryst Pharmaceuticals (BCRX) stock has been relatively weak recently, with the price down 0.7% on the day, 1.9% over the past week, and 2.4% over the past month.
Over the past 3 months the stock has fallen 3.9%, and it is down 24.3% over the past year, despite being up 12.1% year to date. This pattern may catch the attention of investors tracking biotech volatility.
See our latest analysis for BioCryst Pharmaceuticals.
At a share price of $8.41, BioCryst...